News
Stay Up-To-Date on NEXT Oncology
- All
- NEXT Oncology Blog
- NEXT Oncology News
- Press Releases
ORIC Pharmaceuticals to Present Initial Phase 1b Clinical Data for ORIC 114 in EGFR/HER2 Exon 20 Mutated NSCLC at the European Society of Medical Oncology (ESMO) Congress 2023
SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Oct. 17, 2023 (GLOBE NEWSWIRE) — ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms …
Incendia Therapeutics Announces Upcoming Presentations at the European Society for Medical Oncology Congress 2023
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Incendia Therapeutics, formerly Parthenon Therapeutics, a precision oncology company discovering and developing a novel class of therapies that reprogram the tumor microenvironment (TME), today announced that it will …
NEXT Oncology and MediLink Team Up on Phase 1 Clinical Trial
FOR IMMEDIATE RELEASE DATE: October 9, 2023 Contact: Lisa Owens, 210-601-6647 NEXT Oncology and MediLink Therapeutics Take “Team Approach” to Next Level on Phase 1 First in Human Clinical Trial …
Solid Tumors: First-in-human trial of CBX-12 an Alphalex PDC
Ismael Rodriguez Rivera, MD, Medical Oncologist and Clinical Investigator from NEXT Oncology, has conducted a groundbreaking study on a novel therapeutic approach for patients with advanced or metastatic solid tumors. Read …
ZielBio to Present Interim Findings from its Phase 1/2
ZielBio, Inc., a clinical stage biotechnology company discovering new treatments for cancer and other serious diseases, will present the first set of clinical data from its lead asset, ZB131, directed …
Machine Learning in the Diagnosis of Gastric Cancer and Pulmonary Nodule Workup
Machine learning algorithms are increasingly being applied across different areas of medicine and oncology to analyze large data sets and draw conclusions that may otherwise escape the human eye. Indeed, …
Worldwide Clinical Trials Expands Site Alliance Collaboration to Support Oncology Trials
RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–In response to the growing and ever-changing clinical research landscape and the need to bring innovative treatments to patients faster, Worldwide Clinical Trials (Worldwide), a leading global, full-service …
NEXT Oncology is the perfect place to compassionately improve outcomes for patients with cancer, now and in the future.
“Cancer has no geographic boundaries,” said Dr. Tolcher, CEO and founder of NEXT Oncology. “One of the continuing challenges has been that cancer research has been conducted in silos. Our goal …
Drug Development in Gastric Cancer: Are We at an Inflection Point?
Gastric cancer drug development has long been thwarted by the challenges of identifying effective targets and developing drugs against the backdrop of the cancer’s inherent tumor heterogeneity.1 Recently, however, advances in …
Update on Conservative Management of the Axilla when the Sentinel Node is Positive in Breast cancer.
Research remains an essential part of cancer care. In this blog, we will provide information about recent updates or new approvals as it applies to breast cancer written by Dr. …